| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | NADH oxidase H202-forming activity | 5.90e-06 | 2 | 49 | 2 | GO:0106293 | |
| GeneOntologyMolecularFunction | NADPH oxidase H202-forming activity | 5.87e-05 | 5 | 49 | 2 | GO:0106294 | |
| GeneOntologyMolecularFunction | phospholipase D activity | 1.64e-04 | 8 | 49 | 2 | GO:0004630 | |
| GeneOntologyMolecularFunction | NAD(P)H oxidase H2O2-forming activity | 3.83e-04 | 12 | 49 | 2 | GO:0016174 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 3.83e-04 | 12 | 49 | 2 | GO:0016175 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 8.80e-04 | 18 | 49 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 1.09e-03 | 20 | 49 | 2 | GO:0050664 | |
| GeneOntologyBiologicalProcess | cuticle development | 1.66e-05 | 3 | 49 | 2 | GO:0042335 | |
| GeneOntologyBiologicalProcess | cilium assembly | 8.04e-05 | 444 | 49 | 7 | GO:0060271 | |
| GeneOntologyCellularComponent | axoneme | 8.60e-06 | 207 | 49 | 6 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 8.84e-06 | 208 | 49 | 6 | GO:0097014 | |
| GeneOntologyCellularComponent | cytoplasmic region | 1.95e-05 | 360 | 49 | 7 | GO:0099568 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 9.37e-05 | 317 | 49 | 6 | GO:0032838 | |
| GeneOntologyCellularComponent | leading edge membrane | 1.30e-04 | 210 | 49 | 5 | GO:0031256 | |
| GeneOntologyCellularComponent | sperm flagellum | 1.42e-04 | 214 | 49 | 5 | GO:0036126 | |
| GeneOntologyCellularComponent | cell leading edge | 1.55e-04 | 500 | 49 | 7 | GO:0031252 | |
| GeneOntologyCellularComponent | cilium | 2.09e-04 | 898 | 49 | 9 | GO:0005929 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 2.33e-04 | 238 | 49 | 5 | GO:0097729 | |
| GeneOntologyCellularComponent | inner dynein arm | 2.39e-04 | 10 | 49 | 2 | GO:0036156 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic specialization membrane | 3.50e-04 | 12 | 49 | 2 | GO:0098892 | |
| GeneOntologyCellularComponent | cell projection membrane | 4.90e-04 | 431 | 49 | 6 | GO:0031253 | |
| GeneOntologyCellularComponent | NADPH oxidase complex | 8.04e-04 | 18 | 49 | 2 | GO:0043020 | |
| GeneOntologyCellularComponent | extrinsic component of postsynaptic membrane | 1.21e-03 | 22 | 49 | 2 | GO:0098890 | |
| GeneOntologyCellularComponent | motile cilium | 1.42e-03 | 355 | 49 | 5 | GO:0031514 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.56e-03 | 25 | 49 | 2 | GO:0005858 | |
| GeneOntologyCellularComponent | ruffle membrane | 2.08e-03 | 108 | 49 | 3 | GO:0032587 | |
| GeneOntologyCellularComponent | inhibitory synapse | 2.40e-03 | 31 | 49 | 2 | GO:0060077 | |
| GeneOntologyCellularComponent | ribbon synapse | 2.55e-03 | 32 | 49 | 2 | GO:0097470 | |
| GeneOntologyCellularComponent | synaptic cleft | 2.71e-03 | 33 | 49 | 2 | GO:0043083 | |
| GeneOntologyCellularComponent | extrinsic component of synaptic membrane | 3.05e-03 | 35 | 49 | 2 | GO:0099243 | |
| GeneOntologyCellularComponent | presynaptic active zone | 4.41e-03 | 141 | 49 | 3 | GO:0048786 | |
| GeneOntologyCellularComponent | parallel fiber to Purkinje cell synapse | 4.57e-03 | 43 | 49 | 2 | GO:0098688 | |
| Domain | DUOX1 | 6.47e-06 | 2 | 48 | 2 | IPR029595 | |
| Domain | EF-hand_1 | 4.32e-05 | 152 | 48 | 5 | PF00036 | |
| Domain | EF_Hand_1_Ca_BS | 8.43e-05 | 175 | 48 | 5 | IPR018247 | |
| Domain | DUF3669_Znf | 9.64e-05 | 6 | 48 | 2 | IPR022137 | |
| Domain | DUF3669 | 9.64e-05 | 6 | 48 | 2 | PF12417 | |
| Domain | PLDc | 9.64e-05 | 6 | 48 | 2 | SM00155 | |
| Domain | PLD | 1.35e-04 | 7 | 48 | 2 | PS50035 | |
| Domain | PLipase_D/transphosphatidylase | 1.35e-04 | 7 | 48 | 2 | IPR001736 | |
| Domain | NAD_binding_6 | 1.35e-04 | 7 | 48 | 2 | PF08030 | |
| Domain | FAD-bd_8 | 1.35e-04 | 7 | 48 | 2 | IPR013112 | |
| Domain | Fe_red_NAD-bd_6 | 1.35e-04 | 7 | 48 | 2 | IPR013121 | |
| Domain | FAD_binding_8 | 1.35e-04 | 7 | 48 | 2 | PF08022 | |
| Domain | EF_HAND_1 | 1.73e-04 | 204 | 48 | 5 | PS00018 | |
| Domain | Haem_peroxidase | 2.87e-04 | 10 | 48 | 2 | IPR010255 | |
| Domain | An_peroxidase | 2.87e-04 | 10 | 48 | 2 | PF03098 | |
| Domain | PEROXIDASE_3 | 2.87e-04 | 10 | 48 | 2 | PS50292 | |
| Domain | - | 2.87e-04 | 10 | 48 | 2 | 1.10.640.10 | |
| Domain | Haem_peroxidase_animal | 2.87e-04 | 10 | 48 | 2 | IPR019791 | |
| Domain | EF_HAND_2 | 3.08e-04 | 231 | 48 | 5 | PS50222 | |
| Domain | EF_hand_dom | 3.14e-04 | 232 | 48 | 5 | IPR002048 | |
| Domain | Fe3_Rdtase_TM_dom | 4.20e-04 | 12 | 48 | 2 | IPR013130 | |
| Domain | Ferric_reduct | 4.20e-04 | 12 | 48 | 2 | PF01794 | |
| Domain | - | 5.38e-04 | 261 | 48 | 5 | 1.10.238.10 | |
| Domain | Dynein_HC_stalk | 5.77e-04 | 14 | 48 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.77e-04 | 14 | 48 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.77e-04 | 14 | 48 | 2 | PF08393 | |
| Domain | MT | 5.77e-04 | 14 | 48 | 2 | PF12777 | |
| Domain | DHC_fam | 6.65e-04 | 15 | 48 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 6.65e-04 | 15 | 48 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 6.65e-04 | 15 | 48 | 2 | PF03028 | |
| Domain | EFh | 7.18e-04 | 158 | 48 | 4 | SM00054 | |
| Domain | EF-hand-dom_pair | 8.25e-04 | 287 | 48 | 5 | IPR011992 | |
| Domain | Fd_Rdtase_FAD-bd | 1.08e-03 | 19 | 48 | 2 | IPR017927 | |
| Domain | FAD_FR | 1.08e-03 | 19 | 48 | 2 | PS51384 | |
| Domain | Riboflavin_synthase-like_b-brl | 1.08e-03 | 19 | 48 | 2 | IPR017938 | |
| Domain | IQ | 1.76e-03 | 93 | 48 | 3 | PS50096 | |
| Domain | Homeobox | 3.03e-03 | 234 | 48 | 4 | PF00046 | |
| Domain | HOMEOBOX_1 | 3.13e-03 | 236 | 48 | 4 | PS00027 | |
| Domain | HOX | 3.18e-03 | 237 | 48 | 4 | SM00389 | |
| Domain | Homeobox_dom | 3.27e-03 | 239 | 48 | 4 | IPR001356 | |
| Domain | HOMEOBOX_2 | 3.27e-03 | 239 | 48 | 4 | PS50071 | |
| Domain | - | 5.95e-03 | 283 | 48 | 4 | 1.10.10.60 | |
| Domain | - | 9.20e-03 | 321 | 48 | 4 | 3.80.10.10 | |
| Domain | L_dom-like | 9.90e-03 | 328 | 48 | 4 | IPR032675 | |
| Domain | Homeodomain-like | 1.03e-02 | 332 | 48 | 4 | IPR009057 | |
| Domain | Homeobox_CS | 1.21e-02 | 186 | 48 | 3 | IPR017970 | |
| Pathway | REACTOME_SYNTHESIS_OF_PG | 1.39e-04 | 8 | 32 | 2 | M26961 | |
| Pathway | REACTOME_THYROXINE_BIOSYNTHESIS | 1.78e-04 | 9 | 32 | 2 | MM14833 | |
| Pathway | REACTOME_THYROXINE_BIOSYNTHESIS | 2.22e-04 | 10 | 32 | 2 | M27120 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY | 4.47e-04 | 14 | 32 | 2 | M47414 | |
| Pathway | REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES | 6.65e-04 | 17 | 32 | 2 | MM14829 | |
| Pathway | REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES | 7.47e-04 | 18 | 32 | 2 | M27118 | |
| Pubmed | Digenic DUOX1 and DUOX2 Mutations in Cases With Congenital Hypothyroidism. | 1.94e-06 | 2 | 49 | 2 | 28633507 | |
| Pubmed | Dual oxidase-2 has an intrinsic Ca2+-dependent H2O2-generating activity. | 1.94e-06 | 2 | 49 | 2 | 15972824 | |
| Pubmed | Congenital Hypothyroidism due to Oligogenic Mutations in Two Sudanese Families. | 1.94e-06 | 2 | 49 | 2 | 30375286 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 25586178 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 23362256 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 19144650 | ||
| Pubmed | Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. | 1.94e-06 | 2 | 49 | 2 | 10806195 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 11514595 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 16111680 | ||
| Pubmed | Roles of DUOX-mediated hydrogen peroxide in metabolism, host defense, and signaling. | 1.94e-06 | 2 | 49 | 2 | 24161126 | |
| Pubmed | Reactive oxygen species regulate the levels of dual oxidase (Duox1-2) in human neuroblastoma cells. | 1.94e-06 | 2 | 49 | 2 | 22523549 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 11762710 | ||
| Pubmed | Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system. | 1.94e-06 | 2 | 49 | 2 | 11822874 | |
| Pubmed | Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases. | 1.94e-06 | 2 | 49 | 2 | 11753072 | |
| Pubmed | Expression of dual oxidases and secreted cytokines in chronic rhinosinusitis. | 1.94e-06 | 2 | 49 | 2 | 23281318 | |
| Pubmed | Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer. | 1.94e-06 | 2 | 49 | 2 | 18281478 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 15062544 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 31706280 | ||
| Pubmed | Regulated hydrogen peroxide production by Duox in human airway epithelial cells. | 1.94e-06 | 2 | 49 | 2 | 15677770 | |
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 11443211 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 10601291 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 18177232 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 24128054 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 18486455 | ||
| Pubmed | Dual oxidases represent novel hydrogen peroxide sources supporting mucosal surface host defense. | 1.94e-06 | 2 | 49 | 2 | 12824283 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 21915726 | ||
| Pubmed | NADPH oxidase-dependent acid production in airway epithelial cells. | 5.83e-06 | 3 | 49 | 2 | 15210697 | |
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 24164541 | ||
| Pubmed | DUOX enzyme activity promotes AKT signalling in prostate cancer cells. | 5.83e-06 | 3 | 49 | 2 | 23225414 | |
| Pubmed | Association of duoxes with thyroid peroxidase and its regulation in thyrocytes. | 5.83e-06 | 3 | 49 | 2 | 19952225 | |
| Pubmed | Nox4 and Duox1/2 Mediate Redox Activation of Mesenchymal Cell Migration by PDGF. | 1.16e-05 | 4 | 49 | 2 | 27110716 | |
| Pubmed | The type of DUOX-dependent ROS production is dictated by defined sequences in DUOXA. | 1.16e-05 | 4 | 49 | 2 | 22814254 | |
| Pubmed | Heterodimerization controls localization of Duox-DuoxA NADPH oxidases in airway cells. | 1.16e-05 | 4 | 49 | 2 | 19339556 | |
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 16478776 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 34784249 | ||
| Pubmed | Identification of a novel partner of duox: EFP1, a thioredoxin-related protein. | 1.94e-05 | 5 | 49 | 2 | 15561711 | |
| Pubmed | Gatm, a creatine synthesis enzyme, is imprinted in mouse placenta. | 2.91e-05 | 6 | 49 | 2 | 12671064 | |
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 17332529 | ||
| Pubmed | APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury. | 2.91e-05 | 6 | 49 | 2 | 28165467 | |
| Pubmed | Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase. | 4.07e-05 | 7 | 49 | 2 | 19005069 | |
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 16608528 | ||
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 30755476 | ||
| Pubmed | The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. | 1.06e-04 | 11 | 49 | 2 | 16815997 | |
| Pubmed | Reduced expression of neuropeptide genes in a genome-wide screen of a secretion-deficient mouse. | 1.18e-04 | 67 | 49 | 3 | 16987237 | |
| Pubmed | 1.62e-04 | 1442 | 49 | 9 | 35575683 | ||
| Pubmed | Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. | 2.93e-04 | 91 | 49 | 3 | 21833088 | |
| Pubmed | A year of COVID-19 GWAS results from the GRASP portal reveals potential genetic risk factors. | 3.64e-04 | 20 | 49 | 2 | 35224516 | |
| Pubmed | 4.09e-04 | 102 | 49 | 3 | 31623628 | ||
| Pubmed | Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice. | 6.18e-04 | 26 | 49 | 2 | 33905568 | |
| Pubmed | NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure. | 6.67e-04 | 27 | 49 | 2 | 23359859 | |
| Pubmed | 7.71e-04 | 29 | 49 | 2 | 23396134 | ||
| Pubmed | 7.93e-04 | 128 | 49 | 3 | 30995482 | ||
| Pubmed | Med12 is essential for early mouse development and for canonical Wnt and Wnt/PCP signaling. | 8.25e-04 | 30 | 49 | 2 | 20630950 | |
| Pubmed | 1.06e-03 | 34 | 49 | 2 | 12086465 | ||
| Pubmed | Negative regulation of Shh levels by Kras and Fgfr2 during hair follicle development. | 1.06e-03 | 34 | 49 | 2 | 23123965 | |
| Pubmed | HAUSP regulates c-MYC expression via de-ubiquitination of TRRAP. | 1.06e-03 | 34 | 49 | 2 | 25925205 | |
| Cytoband | 15q15.3 | 3.30e-04 | 25 | 49 | 2 | 15q15.3 | |
| Cytoband | 3p14.3 | 4.76e-04 | 30 | 49 | 2 | 3p14.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q21 | 9.11e-04 | 177 | 49 | 3 | chr15q21 | |
| Cytoband | 7q36.1 | 2.87e-03 | 74 | 49 | 2 | 7q36.1 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 2.91e-05 | 92 | 35 | 4 | 521 | |
| GeneFamily | EF-hand domain containing | 6.01e-05 | 219 | 35 | 5 | 863 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.20e-03 | 36 | 35 | 2 | 823 | |
| GeneFamily | Phospholipases | 2.99e-03 | 42 | 35 | 2 | 467 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-06 | 171 | 49 | 5 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-06 | 179 | 49 | 5 | 948c2a01ec7a626c68281e6e796a9f0527a88591 | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-club_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.65e-06 | 181 | 49 | 5 | 60a91587c59029a34e7bec1255083337fe21b72a | |
| ToppCell | P07-Epithelial-airway_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.79e-06 | 184 | 49 | 5 | a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-club_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.79e-06 | 184 | 49 | 5 | ab469b9e06212462cbe2e4db8775c6778db855e6 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.79e-06 | 184 | 49 | 5 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.88e-06 | 186 | 49 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.88e-06 | 186 | 49 | 5 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.98e-06 | 188 | 49 | 5 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-06 | 189 | 49 | 5 | b55de812043b670cbde810d7d42f45909b6d66ef | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-06 | 189 | 49 | 5 | 4e83e49d1265ffe507fdb72924c77c4d1c73f0bd | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-06 | 191 | 49 | 5 | 649fcb62ad15de2f83e61591e43923a717664ae7 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-06 | 191 | 49 | 5 | 9621e22e14ea069f22713947c9faa2d882abe5fe | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-06 | 191 | 49 | 5 | bda8faf92495c8b362850c0aff4fc6fbdd9c563b | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-06 | 191 | 49 | 5 | 6880fb348bb0915db9a5da4f3566ca9ff93ed258 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-06 | 191 | 49 | 5 | 6a8fc9dc1a4c7115862e8f20204fa2f95e50e22f | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-06 | 192 | 49 | 5 | b5cdc2dae3154b1e4ade88f841f38584402ffe33 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-06 | 192 | 49 | 5 | 2d8d5a38e205339eda9c8aca1ca9ba3dcbe5ae56 | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.31e-06 | 194 | 49 | 5 | f15e81ff12525523c62d13105cf264ea72205e2e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-06 | 194 | 49 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.31e-06 | 194 | 49 | 5 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 2.31e-06 | 194 | 49 | 5 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | proximal-3-Hematologic-IGSF21+_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.37e-06 | 195 | 49 | 5 | 8592d0332bc82a91e173680cfd1afc5ee189b289 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.37e-06 | 195 | 49 | 5 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | proximal-Hematologic-IGSF21+_Dendritic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.37e-06 | 195 | 49 | 5 | c48ff83c48342875f06c6c9e7d5bc6084a992848 | |
| ToppCell | proximal-Hematologic-IGSF21+_Dendritic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.37e-06 | 195 | 49 | 5 | ae9d61011e95f7840cbb154738c79745fd29943e | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.43e-06 | 196 | 49 | 5 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.43e-06 | 196 | 49 | 5 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.43e-06 | 196 | 49 | 5 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.43e-06 | 196 | 49 | 5 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.43e-06 | 196 | 49 | 5 | 97e26622d9582b092c18ff5b7e957818f99d9631 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.43e-06 | 196 | 49 | 5 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.43e-06 | 196 | 49 | 5 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.43e-06 | 196 | 49 | 5 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.43e-06 | 196 | 49 | 5 | f429f045ba45e24717963315832150b12a115bfa | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 2.49e-06 | 197 | 49 | 5 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.49e-06 | 197 | 49 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.56e-06 | 198 | 49 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | distal-Epithelial-Ciliated-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.62e-06 | 199 | 49 | 5 | 2de1fe124737a6cca4b3805ab3056f9d9d7c16c7 | |
| ToppCell | distal-3-Epithelial-Ciliated|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.62e-06 | 199 | 49 | 5 | 7e5f29f4ec1fea92f2c0064eea151d2d474ef904 | |
| ToppCell | distal-Epithelial-Ciliated-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.62e-06 | 199 | 49 | 5 | 6ce0df4a6f4d9353919e26ffab97c9ec89911da6 | |
| ToppCell | distal-Epithelial-Ciliated|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.62e-06 | 199 | 49 | 5 | 18ca031cfe702afb9bf94e03c0f3680c38e7599e | |
| ToppCell | distal-2-Epithelial-Ciliated|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.62e-06 | 199 | 49 | 5 | 97b66b82c76c7bc1fcd7da7b94dd2aa2d4d70a60 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.69e-06 | 200 | 49 | 5 | 9ae434c78e08adf95da49c85616e3ca72d1227bf | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | 12bc7d95c4166d12487081a76d210b7abe5991b0 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.69e-06 | 200 | 49 | 5 | ddd39b754bfaa98249d497dfb7e97ec58617a11a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.69e-06 | 200 | 49 | 5 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | 926a7ea94b5908aebf103893ea83ce9d25285b65 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.69e-06 | 200 | 49 | 5 | 85c98da55f7cd4ffdf9d309b56c8cc5d43f3c04c | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-Ciliated|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.69e-06 | 200 | 49 | 5 | a521cf837cadf280505ff9d7e641a205af7d6513 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.69e-06 | 200 | 49 | 5 | 918b576fd9491d23c2bb9d663fa5fb3505cb1c7e | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.69e-06 | 200 | 49 | 5 | 4992dbf0514d674017315dbd20d91dfec0c608e9 | |
| ToppCell | VE-CD4-CD8_1|VE / Condition, Cell_class and T cell subcluster | 1.02e-05 | 123 | 49 | 4 | bc0f509716bb71d6e3fa343f4920ecb80eb62794 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-midbrain/hindbrain_cells|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.48e-05 | 154 | 49 | 4 | df1b58a20af73fa79c6c069c0117a9ffd85b476f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-05 | 155 | 49 | 4 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-05 | 155 | 49 | 4 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.68e-05 | 157 | 49 | 4 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.57e-05 | 169 | 49 | 4 | 16c52a0f6d96ecc1832922fce9b39691849f0d73 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.57e-05 | 169 | 49 | 4 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-05 | 173 | 49 | 4 | a40a52d8041d45dc3bef74fe55945ae07aa018d6 | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-05 | 173 | 49 | 4 | f0b4dd1cf41d6ee6abb0e1968b8b39f4fabebcb5 | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.91e-05 | 173 | 49 | 4 | f3f67531f72d6d52e19c7f1f2db1ab4026fb70da | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.91e-05 | 173 | 49 | 4 | 81c36b9fe02c59099f080b2db02f4eaf2783911f | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-05 | 177 | 49 | 4 | 1dc69c661e70e7e22bd9d7cf953eb638da9fd43c | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.27e-05 | 177 | 49 | 4 | 426a9845df7fd13b02e744532c336c60bc4d4a22 | |
| ToppCell | control-Others-CD34+_GATA2+_cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.37e-05 | 178 | 49 | 4 | 2120bd3e099b0b271bf079db9827a2f3eee2f909 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-05 | 180 | 49 | 4 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.56e-05 | 180 | 49 | 4 | adf5db5bfa9a38b1227ab0beccd8d6f3eea67ac0 | |
| ToppCell | P03-Epithelial-airway_epithelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.66e-05 | 181 | 49 | 4 | 1ea21d860d4d7abab3e21e130a16d044006656ee | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.76e-05 | 182 | 49 | 4 | ba066ff9029cc052b76e2330ec168cb2e9b7e498 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 4.76e-05 | 182 | 49 | 4 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.97e-05 | 184 | 49 | 4 | 924400f47e6b2cdf7b0d538df75857935cf0209b | |
| ToppCell | 15-Trachea-Epithelial-Multiciliated_precursor|Trachea / Age, Tissue, Lineage and Cell class | 5.07e-05 | 185 | 49 | 4 | 9a8b8360d99375b726ca8e3c9a3f9b08919892d7 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 5.07e-05 | 185 | 49 | 4 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.07e-05 | 185 | 49 | 4 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | P28-Epithelial-airway_epithelial_cell-club_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.18e-05 | 186 | 49 | 4 | a26811481668fa25c48a064a56c198685693ad8d | |
| ToppCell | P28-Epithelial-airway_epithelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.18e-05 | 186 | 49 | 4 | df80f101954b8ec6ccdb03e702de22e70b65181f | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.18e-05 | 186 | 49 | 4 | 88e6246172d816806a498a5c1f38e699f2f5d7c2 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 187 | 49 | 4 | 04dba2ed09ee4180830bdf0191921696697ea234 | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.29e-05 | 187 | 49 | 4 | 1bba994aaaa9825b54aaeaff3829850267bc4602 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 187 | 49 | 4 | 805dafe22f835ece4dd091d8030d0a63b52a48dd | |
| ToppCell | droplet-Lung-3m-Epithelial-airway_epithelial-lung_ciliated_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.29e-05 | 187 | 49 | 4 | d6ac351e7aeba98851d308c14ac395044fe4fbbb | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 5.40e-05 | 188 | 49 | 4 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Fibroblast-A|World / shred on cell class and cell subclass (v4) | 5.40e-05 | 188 | 49 | 4 | 6740bed5fb8f45b6eea17041894b804214c2a4ae | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.40e-05 | 188 | 49 | 4 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 189 | 49 | 4 | 28c750ac56e3861fe7280e32839a4d8ce8bd8692 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.51e-05 | 189 | 49 | 4 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.51e-05 | 189 | 49 | 4 | 57ab947b81dbd9d3e896be89e28c4a62cf720837 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-F_(Ciliated)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.51e-05 | 189 | 49 | 4 | ebc16b8eab84167d74446783d7e802acedc6b9c6 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.51e-05 | 189 | 49 | 4 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.51e-05 | 189 | 49 | 4 | a3cd4c2da4feb9bdcd8957f3e344d095da1367b8 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 189 | 49 | 4 | efee01edd171bf569267b672fab05c421de6c92d | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.51e-05 | 189 | 49 | 4 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.51e-05 | 189 | 49 | 4 | a85099bd598a27ee64ee0664d051d89fa8d62fc9 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 5.51e-05 | 189 | 49 | 4 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 5.51e-05 | 189 | 49 | 4 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.51e-05 | 189 | 49 | 4 | 93b1026bb1ba759e5704561c9a5de14a30c08894 | |
| Disease | phenylketonuria (implicated_via_orthology) | 1.42e-05 | 4 | 46 | 2 | DOID:9281 (implicated_via_orthology) | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 8.50e-05 | 9 | 46 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | hypothyroidism (implicated_via_orthology) | 1.83e-04 | 13 | 46 | 2 | DOID:1459 (implicated_via_orthology) | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 2.14e-04 | 14 | 46 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | facial emotion recognition measurement | 1.37e-03 | 35 | 46 | 2 | EFO_0008329 | |
| Disease | response to simvastatin, myopathy | 1.88e-03 | 41 | 46 | 2 | EFO_0004145, GO_1903491 | |
| Disease | Amyotrophic Lateral Sclerosis, Sporadic | 2.56e-03 | 48 | 46 | 2 | C1862941 | |
| Disease | Amyotrophic Lateral Sclerosis, Familial | 2.56e-03 | 48 | 46 | 2 | C4551993 | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 2.78e-03 | 50 | 46 | 2 | C1862939 | |
| Disease | disease recurrence, colon carcinoma | 2.89e-03 | 51 | 46 | 2 | EFO_0004952, EFO_1001950 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DQRRGLFSVWQEVFQ | 581 | Q8WVB6 | |
| LNLTEDRVQVWFQNR | 176 | Q8N693 | |
| RFNARQFISWLQDVD | 2581 | Q6UB99 | |
| LQQQDVERWLGFITF | 466 | O43310 | |
| RLPEWEEQIVFNENF | 416 | Q8N157 | |
| EQWEAERRELQFIVQ | 211 | Q6TFL3 | |
| WETRQVVIEFDQNVF | 616 | Q9BQL6 | |
| FLWQLEDIRQRYEQQ | 646 | Q8N8E3 | |
| LDNRIWFRNFQIIEE | 211 | Q8TDN6 | |
| LLEFADRINQVWQNE | 1131 | Q96M86 | |
| WVQTERQQFRDFRDL | 241 | Q96D15 | |
| FIQWFQRQQLLTEEE | 476 | Q9NZL6 | |
| QRQFEWLADIIREVE | 1426 | Q9NRD9 | |
| FWAAVERFNNEQRLR | 1481 | Q9P2P5 | |
| EDQRVFNFDVRQLNW | 416 | Q96K12 | |
| NWQRIDLFNFQTDVE | 51 | Q9UKC9 | |
| DLFVWNVLNREEVNI | 26 | Q9NPP4 | |
| RTQRQFEWLADIIQE | 1421 | Q9NRD8 | |
| QQFIQRWVRLDEREF | 281 | P42263 | |
| FAEELEWERQEIQRF | 3231 | Q9Y6V0 | |
| NLEEDRIQIWFQNRR | 146 | Q9UBX0 | |
| RLERAQVLVNQFWET | 1901 | O94854 | |
| LLQQFQTAWREAEFV | 876 | Q86UK5 | |
| QFNRRVLIDLFIWND | 226 | Q495T6 | |
| WEFEQIQDNVRRQSS | 246 | Q9UGQ3 | |
| ATVQEQLRQLFERDW | 471 | Q96BZ4 | |
| FRWFFLVNDEENQIR | 1201 | Q4G0P3 | |
| QEEAFRFLWNQVRSL | 621 | Q8IW35 | |
| WAEQERNEFVRQLEF | 106 | Q9NWQ9 | |
| EFWRQEELTRINQSF | 411 | Q8NA54 | |
| DFRNILRIDNLWQFE | 51 | Q9H069 | |
| WDQVRDEIQREFDQE | 1316 | Q9P225 | |
| EINTEESRIQIWFQN | 51 | A6NLW8 | |
| VVRERIWQNSDFNFD | 1071 | Q01668 | |
| ELEEWQLQQRRQGFI | 426 | Q8NEH6 | |
| RLFLEEFERIWEQFN | 196 | Q8N2A8 | |
| ALVEINRREVEQWFA | 276 | O76011 | |
| VLQAWQRRFVQLAQE | 351 | Q9Y6C5 | |
| FNIWDRVLRAQEIVN | 376 | P47972 | |
| LVWRNNERLQEFVLV | 1021 | O94966 | |
| NLTVQERERFTVQEW | 51 | Q6ZVK1 | |
| LDQIFVWEQNLEQFQ | 601 | Q13009 | |
| EQEILWAINDIIRNF | 111 | P36537 | |
| LENVENLLRNRNFWI | 111 | Q9UDV6 | |
| LENVENLLRNRNFWI | 81 | Q6NUN9 | |
| RQQQEEEQRRDFTWQ | 756 | Q07283 | |
| RLDLVESRVQVWFQN | 141 | A6NJT0 | |
| RFEEALQTIFNRWRA | 771 | O94832 | |
| EQALRFEQERRTWQE | 481 | O15049 |